A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
Clinical trial NCT00920257 · COMPLETED
Trial details
- NCT number
- NCT00920257
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-16
- Primary completion
- 2013-04-17
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.